OMNICELL, INC. — Director's Dealing 2022

Dec 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2022-12-01

Reporting Person: LIPPS RANDALL A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-01	Common Stock	M	2500	$17.2900	Acquired	90848	Direct
2022-12-01	Common Stock	S	1600	$50.4888	Disposed	89248	Direct
2022-12-01	Common Stock	S	900	$51.2889	Disposed	88348	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-01	Stock Option NQ (Right to Buy)	$17.29	M	2500	Disposed	2023-02-04	Common Stock (2500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	302049	Indirect
Common Stock	8051	Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021.

F2: The balance is adjusted to reflect 211 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/22.

F3: The price reported in Column 4 is a weighted average price of $50.4888. The sold price range between $49.97 to $50.92. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price of $51.2889. The sold price range between $50.98 to $51.77. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Shares held in trust with Mr. Lipps' wife.

F6: Shares held in trust for the benefit of Mr. Lipps' children.